Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety

NCT06656806 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: Measure concentrations of CBD in spot urine collections from subjects treated with inhaled CBD
DRUG: Determine the presence and concentration of CBD in subject's plasma with inhaled CBD

Sponsor

Trinity Hypertension & Metabolic Research Institute

Collaborators

[object Object]